A P Policy & Procedure: Ntibiotic Olicy
A P Policy & Procedure: Ntibiotic Olicy
A P Policy & Procedure: Ntibiotic Olicy
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
ANTIBIOTIC POLICY
POLICY & PROCEDURE
Page 1 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
INTRODUCTION
Antibiotics are essential treatments for serious infections. They are one of the most
important and valuable discoveries of modern medicine. However administration of antibiotics
can lead to the selection of antibiotic-resistant organisms. These organisms can give rise to
healthcare-associated infections which are associated with increased morbidity and mortality.
Therefore it is important to ensure that antibiotics are prescribed in a way which
minimizes the risk of healthcare-associated infections. Hospital Antibiotic Guidelines have been
designed to treat common infections effectively and with the minimum risk of healthcare-
associated infections. The current antibiotic policy describes the procedures to encourage the use
of the Antibiotic Guidelines and to ensure that antibiotics are not prescribed in a way which is
likely to lead to healthcare-associated infections.
This policy deals with the processes by which recommendations for specific antibiotic
treatments are made and the procedures to support these recommendations. It does not provide
specific advice on which antibiotics should be used in specific infections as this is covered in the
Drug Formulary Antibiotic Guidelines. This policy also does not provide information on which
antibiotics are regarded as having the highest risk of causing healthcare-associated infections nor
on which antibiotics can only be used following advice from a microbiologist or infectious
diseases physician. This is because this will vary between clinical areas depending on recent
infection surveillance data.
Page 2 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Ideally, an antimicrobial agent for surgical prophylaxis should (1) prevent SSI, (2) prevent SSI-
related morbidity and mortality, (3) reduce the duration and cost of health care (when the costs
associated with the management of SSI are considered, the cost-effectiveness of prophylaxis
becomes evident), (4) produce no adverse effects, and (5) have no adverse consequences for the
microbial flora of the patient or the hospital.53
To achieve these goals, an antimicrobial agent should be (1) active against the pathogens most
likely to contaminate the surgical site, (2) given in an appropriate dosage and at a time that
ensures adequate serum and tissue concentrations during the period of potential contamination,
(3) safe, and (4) administered for the shortest effective period to minimize adverse effects, the
development of resistance, and costs
These Recommendations are provided for adult (age 19 years or older) and pediatric (age 1–
18years) patients. These guidelines do not specifically address newborn(premature and full-term)
infants.
While the guidelines do not address all concerns for patients with renal or hepatic dysfunction,
antimicrobial prophylaxis often does not need to be modified for these patients when given as a
single preoperative dose before surgical incision.
The recommendations herein may not be appropriate for use in all clinical situations. Decisions
to follow these recommendations must be based on the judgment of the clinician and
consideration of individual patient circumstances and available resources.
a. Preoperative-dose timing:
Successful prophylaxis requires the delivery of the antimicrobial to the operative site before
contamination occurs. Thus, the antimicrobial agent should be administered at such a time to
provide serum and tissue concentrations exceeding the minimum inhibitory concentration (MIC)
for the probable organisms associated with the procedure, at the time of incision, and for the
duration of the procedure.
Page 3 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Overall, administration of the first dose of antimicrobial beginning within 60 minutes before
surgical incision is recommended.
Administration of vancomycin and fluoroquinolones should begin within 120 minutes before
surgical incision because of the prolonged infusion times required for these drugs. Because these
drugs have long half-lives, this early administration should not compromise serum levels of these
agents during most surgical procedures.
Weight-based dosing: The dosing of most antimicrobials in pediatric patients is based on body
weight, but the dosing of many antimicrobials in adults is not based on body weight, because it is
safe, effective, and convenient to use standardized doses for most of the adult patient population.
However, in obese patients, especially those who are morbidly obese, serum and tissue
concentrations of some drugs may differ from those in normal-weight patients because of
pharmacokinetic alterations that depend on the lipophilicity of the drug and other factors.
Obesity has been recognized as a risk factor for SSI; therefore, optimal dosing of antimicrobial
prophylaxis is needed in these patients.
c. Redosing.
Intraoperative redosing is needed to ensure adequate serum and tissue concentrations of the
antimicrobial if the duration of the procedure exceeds two half-lives of the antimicrobial or there
is excessive blood loss (i.e., >1500 mL)
Page 4 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
The redosing interval should be measured from the time of administration of the preoperative
dose, not from the beginning of the procedure.
Redosing may also be warranted if there are factors that shorten the half-life of the antimicrobial
agent (e.g., extensive burns)
Redosing may not be warranted in patients in whom the half-life of the antimicrobial agent is
prolonged (e.g., patients with renal insufficiency or renal failure)
d. Duration.:
The duration of antimicrobial prophylaxis should be less than 24 hours for most procedures.
A cardiothoracic procedure for which prophylaxis duration of up to 48 hours has been accepted
without evidence to support the practice is an area that remains controversial.
Moreover, prolonged prophylaxis was associated with an increased risk of acquired antimicrobial
resistance compared with short-term prophylaxis
There are no data to support the continuation of antimicrobial prophylaxis until all indwelling
drains and intravascular catheters are removed
e. Drug administration
The preferred route of administration varies with the type of procedure, but for a majority of
procedures, i.v. administration is ideal because it produces rapid, reliable, and predictable serum
and tissue concentrations.
Page 5 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
g. Drug of choice:
For most procedures, cefazolin is the drug of choice for prophylaxis because it is the most widely
studied antimicrobial agent, with proven efficacy. It has a desirable duration of action, spectrum
of activity against organisms commonly encountered in surgery, reasonable safety, and low cost.
Routine use of vancomycin prophylaxis is not recommended for any procedure.8 Vancomycin
may be included in the regimen of choice when a cluster of
MRSA cases (e.g., mediastinitis after cardiac procedures) or methicillinresistant coagulase-
negative staphylococci SSIs have been detected at an institution. Vancomycin prophylaxis
should be considered for patients with known MRSA colonization or at high risk for MRSA
colonization in the absence of surveillance data (e.g., patients with recent hospitalization,
nursing-home residents, hemodialysis patients).
In institutions with SSIs attributable to communityassociated MRSA, antimicrobial agents with
known in vitro activity against this pathogen may be considered as an alternative to vancomycin.
The use of vancomycin for MRSA prophylaxis does not supplant the need for routine surgical
prophylaxis appropriate for the type of procedure.
When vancomycin is used, it can almost always be used as a single dose due to its long half-life.
Patients receiving therapeutic antimicrobials for a remote infection before surgery should also be
given antimicrobial prophylaxis before surgery to ensure adequate serum and tissue levels of
antimicrobials with activity against likely pathogens for the duration of the operation.
If the agents used therapeutically are appropriate for surgical prophylaxis, administering an extra
dose within 60 minutes before surgical incision is sufficient. Otherwise, the antimicrobial
prophylaxis recommended for the planned procedure should be used.
For patients with indwelling tubes or drains, consideration may be given to using prophylactic
agents active against pathogens found in these devices before the procedure, even though
therapeutic treatment for pathogens in drains is not indicated at other times.
For patients with chronic renal failure receiving vancomycin, a preoperative dose of cefazolin
should be considered instead of an extra dose of vancomycin, particularly if the probable
Page 6 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
pathogens associated with the procedure are gram-negative. In most circumstances, elective
surgery should be postponed when the patient has an infection at a remote site.
h. Allergy to b-lactam antimicrobials.
Allergy to b-lactam antimicrobials may be a consideration in the selection of surgical
prophylaxis. The b-lactam antimicrobials, including cephalosporins, are the mainstay of surgical
antimicrobial prophylaxis and are also the most commonly implicated drugs when allergic
reactions occur. Because the predominant organisms in SSIs after clean procedures are gram-
positive, the inclusion of vancomycin may be appropriate for a patient with a life-threatening
allergy to b-lactam antimicrobials.
Although true Type 1 (immunoglobulin E [IgE]-mediated) crossallergic reactions between
penicillins, cephalosporins, and carbapenems are uncommon, cephalosporins and carbapenems
should not be used for surgical prophylaxis in patients with documented or presumed
IgEmediated penicillin allergy.
Refer
Annexure 1: Recommended doses and redosing intervals for commonly used antimicrobials
Annexure 2: Recommendations for surgical antimicrobial prophylaxis
Antibiotic timing Infusion of the first antimicrobial dose should begin within 60 min
before the surgical incision except for vancomycin and quinolones.
When fluroquinolones or vancomycins are indicated, infusions of
the 1st antimicrobial dose should begin within 120 min before the
incision.
Duration of prophylaxis Prophylactic antimicrobials should be discontinued within 24 h
after the end of surgery. Patients who have documented infection
at the time of surgery or within 24 hrs of surgery are excluded
from 24 hrs rule. Additionally post CT surgery patient allowed
upto 48 hrs of treatment.
Screening for b-lactam For those operations for which cephalosporins represent the most
allergy appropriate antimicrobials for prophylaxis, the medical history
should be adequate to determine whether the patient has a history
of allergy or serious adverse antibiotic reaction. Alternative testing
strategies (e.g., skin testing) may be useful for patients with
reported allergy.
Page 7 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 8 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
* To be treated with antibiotics in Pregnant women and Pt’s who underwent urogenital
surgery.
2.3.CATHETER RELATED BLOOD STREAM INFECTIONS: ( Follow the Empirical
Treatment)
Or
Piperacillin + Tazobactum
OR
Imipenem+cilastatin OR Meropenem ( in shock)
2.4.CNS INFECTIONS
2.4.a. Brain abscess – Follow guidelines
Simple Complex (Following surgical procedure, Head
trauma, Inf. Endocarditis)
1. Ceftriaxone 2gms / BD 1. Ceftriaxone 2gms / BD or Ceftazidime
+ / TDS 2gms
Metronidazole 500mg / TDS +
Metronidazole 500mg / TDS +
Vancomycin 30mg / kg / day
1. Ceftazidime 2gms / IV TDS (in
immunosuppressed)
+
Metronidazole 500mg / TDS
2.4.b. Meningitis:
Page 9 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
2.5.PNEUMONIA
Community acquired pneumonia
2.5.a. OUT PATIENT
Page 10 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
2.5.b. IN PATIENT
2. Repeated exacerbation of COPD with recent steroids (10 mg/ d) + antibiotics usage.
5. Malnutrition
6. Immunocompromised state
7. Parenteral feeding
Page 11 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
If patient sepsis send culture & prescribe IV linezolid & Piperecillin Tazobactum
Stable – Augmentin (Amoxicillin-clavulanate)
Page 12 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
3.1.EMPIRICAL ANTIBIOTICS
1. CARDIAC CATHETERISATION
Page 13 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
3. PRE-OPERATIVE PNEUMONIAS
A. Community acquired
1st line - Amoxicillin & clavulanic acid (100 mg/kg/day in 3 divided doses)
2nd line – (Magnex,Cefeperazone Sulbactum)_+Amikacin to be added if required
2nd line- Meropenum,cilaneum+ Amikacin+/- Linezolid
3rd line- Meropenum,cilaneum+ Linezolid +/- Amikacin
3.2.Nosocomial
Cefaperazone-sulbactum _+ Amikacin (15 mg/kg/ day in 3 divided doses
3.3.POST OPERATIVE
Page 14 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
EARLY ONSET HAP WITH PRIOR ANTIBIOTIC USE / LATE ONSET HAP
Amikacin + Cefaperazone
If ESBL rates are high - Start piperacillintazobactum / cefaperazoneSulbactum
If child is sick - meropenem
If MRSA ---- linezolid
Prepared by: Infection control committee Reviewed by: Consultants
chairperson
Page 15 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
3.6. SEPTICEMIA
Ceftriaxone 50
If CNS infection or resistant streptococcus
pneumonia suspected Vancomycin added 40
Metronidazole
If intra-abdominal infection suspected - Clindamycin 30
IMMUNO COMPROMISED
INFECTIVE ENDOCARDITIS
Page 16 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
If cultures are negative, empirical antibiotics are upgraded depending on the type of valve lesion
and the suspected organism according to IAP 2007 guidelines
A. FOR CHEMOPROPHYLAXIS
Cephalexin,Cefuroxime – 10 mg/kg/day in 3-4 divided doses for 6 months
B. TREATMENT (PARENTERAL)
Cefotaxim – 100 – 150 mg/kg/day in 2-3 divided doses
C. TREATMENT (ORAL)
Cephalexim – 10 mg/kg/day in 2 divided doses
Page 17 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
10 Cardarone
a) Infusion a) Dilute in 500
ml 5% dextrose
over 24 hrs
b) Bolous b) in 100 ml NS
over 1/2hrs.
11 Amikacin 100 ml NS over 1hr. No test dose
Annexure 1:
Page 18 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 19 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 20 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Annexure 2:
Page 21 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 22 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 23 of 24
Hospital Antibiotic Policy Date of Issue :
22/02/2017
Document No : Date of Revision:
SH/AP /M/ 01 08/02/2017
Page 24 of 24